Works by Li, Xiaoqi


Results: 204
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks.

    Published in:
    Rheumatology & Therapy, 2020, v. 7, n. 4, p. 759, doi. 10.1007/s40744-020-00225-4
    By:
    • Marzo-Ortega, Helena;
    • Mease, Philip J.;
    • Rahman, Proton;
    • Navarro-Compán, Victoria;
    • Strand, Vibeke;
    • Dougados, Maxime;
    • Combe, Bernard;
    • Wei, James Cheng-Chung;
    • Baraliakos, Xenofon;
    • Hunter, Theresa;
    • Sandoval, David;
    • Li, Xiaoqi;
    • Zhu, Baojin;
    • Bessette, Louis;
    • Deodhar, Atul
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen‐Week Results From a Phase III Randomized, Double‐Blind, Placebo‐Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors

    Published in:
    Arthritis & Rheumatology, 2019, v. 71, n. 4, p. 599, doi. 10.1002/art.40753
    By:
    • Deodhar, Atul;
    • Poddubnyy, Denis;
    • Pacheco‐Tena, Cesar;
    • Salvarani, Carlo;
    • Lespessailles, Eric;
    • Rahman, Proton;
    • Järvinen, Pentti;
    • Sanchez‐Burson, Juan;
    • Gaffney, Karl;
    • Lee, Eun Bong;
    • Krishnan, Eswar;
    • Santisteban, Silvia;
    • Li, Xiaoqi;
    • Zhao, Fangyi;
    • Carlier, Hilde;
    • Reveille, John D.;
    • Antolini, Christopher;
    • Azevedo, Valderilio;
    • Barkham, Magnus;
    • Rodriguez, Aaron Alejandro Barrera
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50